OBJECTIVE: External cephalic version (ECV) is a technique used to reduce the incidence of cesarean deliveries due to malpresentation. Nitrous oxide is used for pain relief for women undergoing ECV. We compared the mode of delivery and success rate in ECV with and without nitrous oxide. STUDY DESIGN: A retrospective cohort analysis was performed including all singleton, term ECVs between January 2016 to June 2017 at a single institution. Multivariable logistic regression was used to compare the success rates in women who had ECV without nitrous oxide versus ECV with nitrous oxide. The primary outcome was rate of ECV success and secondary outcome was rate of vaginal delivery. RESULTS: During the study period, 167 women underwent ECV: 90 without nitrous oxide and 77 with nitrous oxide. 29 (32.2%) of the women without nitrous were successfully converted to cephalic presentation and 8 of these delivered vaginally (27.6%). Of the 77 women who used nitrous, 25 (32.5%) were successful and 8 of these women delivered vaginally (32.2%) (RR 1.00 for rate of conversion, 95% CI 0.6-1.5). After controlling for confounders, use of nitrous oxide had no clinically or statistically significant difference on ECV success rates (OR 1.08, 95% CI 0.52-2.23). CONCLUSION: Nitrous oxide does not seem to affect the success of ECV. More research should be done to determine whether use of nitrous oxide improves patient satisfaction and tolerability of ECV. 
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OBJECTIVE:
The number of women of advanced maternal age (AMA), defined as age 35 years or greater, is increasing in the United States. While AMA women have increased risks for pregnancy complications from increased underlying comorbidities, little is known regarding specific risk factors for postpartum readmissions and associated complications. We evaluated the risk factors for postpartum readmissions and the associated severe morbidity in this population during their 'fourth trimester' . STUDY DESIGN: Using the Nationwide Readmission Database, the 60-day all-cause postpartum readmission risk from 2010 to 2014 was analyzed. Risk for severe morbidity (SMM) during readmission was ascertained using criteria from the Centers for Disease Control and Prevention. The primary exposure of interest was maternal age (15-18, 19-24, 25-34, 35-39, 40-44, and >44 years) . Outcomes included time to readmission, risk of readmission, and risk for SMM during readmission. Multivariable log linear analyses adjusting for patient, obstetric, and hospital factors were conducted to assess these outcomes using risk ratios (RR) with 95% confidence intervals (CI). RESULTS: Between 2010-2014, we identified 15.3 million deliveries, 15% of which were to women aged 35 or older. The 60-day all-cause readmission rate was 1.8%. Of these, 12% were complicated by SMM. Age-stratification revealed that AMA patients had significantly longer readmission lengths of stay, increased risk for readmission, and increased risk for SMM. The majority of readmissions occurred within the first 20 days regardless of age (Figure 1) . In multivariable analysis, AMA patients ages 35-39, 40-44, and >44 years had 11% (RR 1.11, 95% CI 1.09, 1.12), 30% (RR 1.30, 95% CI 1.28, 1.32), and 46% (RR 1.46, 95% CI 1.36, 1.56) significantly higher rates of allcause readmission when compared to 25-34 year old patients. Women 35-39, 40-44, and >44 years of age had a 19% (95% CI 14-25%), 50% (95% CI 41-59%), and 84% (95% CI 48-131%) higher risk of a readmission with SMM than women 25-34 (Table 1) . CONCLUSION: AMA women are at higher risk for both postpartum readmission and severe morbidity during readmission. Women older than 35 years represent the group most likely to experience complications requiring readmission, with the sharpest risk increase after 
The most accurate means of dating a twin gestation by ultrasound is unknown. While limited evidence supports using the crown-rump length from the smaller fetus and 2 nd /3 rd trimester biometric assessments from the larger, societal guidelines favor the larger crown-rump length based on expert opinion. Hence, our objective was to evaluate which ultrasound measurements are most reliable for establishing a twin estimated date of confinement (EDC) through the midpoint of pregnancy. STUDY DESIGN: We collected sonographic measurements for all nonanomalous twin gestations conceived with in vitro fertilization who received care at our facilities over a 10-year period. EDCs were calculated using Hadlock's formulas. The EDCs generated using the smaller, larger, and mean of the two crown rump lengths up to 13w6d and composite biometry up to 22w0d were compared to the true EDC based on the date of oocyte aspiration using paired t-tests. The ultrasound EDC closest to the true EDC was ascertained using Pearson's correlation coefficient. RESULTS: Crown-rump lengths from 132 subjects and second trimester biometric assessments from 138 subjects were identified. While the smaller, larger, and mean crown-rump length calculations all accurately approximated the true EDC, the smaller performed marginally better (0.929 vs. 0.924 and 0.927, respectfully). For second trimester biometric assessments, the EDC using composite biometry from the smaller fetus had the strongest correlation (0.918 vs. 0.778 and 0.882, respectively).
CONCLUSION:
The crown-rump length and second trimester composite biometry from the smaller fetus are most accurate in determining the EDC for a twin gestation by ultrasound. OBJECTIVE: Prior studies and reviews of cervical ripening interventions to initiate labor induction focused on pair-wise comparisons of interventions with regard to select outcomes, making it difficult to establish an overall hierarchy of ideal approaches. We synthesized evidence from a systematic review into a network of 12 cervical ripening interventions and 7 outcomes. STUDY DESIGN: We searched the Cochrane Library and MEDLINE for randomized controlled trials of cervical ripening interventions. Citations were screened in duplicate with discrepancies adjudicated independently. Eligible interventions included vaginal (gel and tablet), oral, and intracervical prostaglandins; amniotomy; vaginal, oral, and buccal/sublingual misoprostol; balloon catheter; and membrane sweeping. Eligible outcomes included vaginal delivery after 24 hours, instrumental delivery, cesarean delivery, uterine hyperstimulation, Apgar score, postpartum hemorrhage, and neonatal intensive care unit admission. A network meta-analysis was conducted in a Bayesian setting, with models for each outcome specified as generalized linear mixed models to account for patient clustering within studies. RESULTS: 312 articles were eligible. Across the 7 outcomes, the number of interventions with data ranged from 8 to 12, and the number of studies and participants, respectively, ranged from 38 and 7,492 (vaginal delivery > 24 hours) to 257 and 47,287 (cesarean delivery). Using cesarean delivery as an example (network shown in Figure) , buccal/sublingual misoprostol and oral misoprostol were among the least likely to result in cesarean delivery while amniotomy and placebo were among the most likely. The favored interventions differed somewhat across outcomes. For example, buccal/sublingual misoprostol was among the most effective interventions for all outcomes except hyperstimulation and balloon catheter was favored for all outcomes except achieving vaginal delivery within 24 hours. Conversely, placebo had high probability of being among the least effective interventions for all outcomes except hyperstimulation. CONCLUSION: The ranking of optimal cervical ripening interventions based on findings of published trials differs by outcome, but buccal/ sublingual misoprostol and balloon catheter were shown to be among the most likely interventions to have favorable outcomes.
A network meta-analysis of cervical ripening interventions

